Publikationen, an denen er mitarbeitet Ferran Nadeu (10)

2023

  1. IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia

    Blood Advances

  2. Unraveling the genetics of transformed splenic marginal zone lymphoma

    Blood Advances, Vol. 7, Núm. 14, pp. 3695-3709

2022

  1. Detection of early seeding of Richter transformation in chronic lymphocytic leukemia

    Nature Medicine, Vol. 28, Núm. 8, pp. 1662-1671

  2. Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma

    British Journal of Haematology, Vol. 196, Núm. 3, pp. 589-598

2019

  1. Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population

    British Journal of Haematology, Vol. 185, Núm. 3, pp. 480-491

  2. Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia

    Haematologica, Vol. 104, Núm. 3, pp. 576-586

2018

  1. Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia

    Leukemia, Vol. 32, Núm. 3, pp. 645-653

  2. Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets

    Leukemia, Vol. 32, Núm. 3, pp. 675-684

  3. The mutational landscape of small lymphocytic lymphoma compared to non-early stage chronic lymphocytic leukemia

    Leukemia and Lymphoma, Vol. 59, Núm. 10, pp. 2318-2326

2016

  1. Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia

    Blood, Vol. 127, Núm. 17, pp. 2122-2130